Ratings by H.C. Wainwright (Patrick Trucchio)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/3/2024 | atai Life Sciences N.V | ATAI | Maintain | Buy (N/A) |
|
Details | ||
| 4/2/2024 | Altimmune | ALT | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2024 | Precision BioSciences Inc. | DTIL | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2024 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 1/23/2024 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 1/18/2024 | Invivyd Inc. | IVVD | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2024 | Gossamer Bio Inc. | GOSS | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2024 | Longboard Pharmaceuticals Inc | LBPH | Maintain | Buy (N/A) |
|
Details | ||
| 11/28/2023 | Freeline | FRLN | Downgrade | Neutral (Buy) |
6.17 (6.48) |
5.02% | Details | |
| 11/17/2023 | Silence Therapeutics | SLN | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2023 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2023 | Precision BioSciences Inc. | DTIL | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2023 | Altimmune | ALT | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2023 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2023 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2023 | Precision BioSciences Inc. | DTIL | Maintain | Buy (N/A) |
|
Details | ||
| 7/25/2023 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2023 | Invivyd Inc. | IVVD | New Coverage | Buy (N/A) |
1.10 (2.07) |
88.18% | Details | |
| 4/5/2023 | Freeline | FRLN | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2023 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 1/19/2023 | atai Life Sciences N.V | ATAI | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2022 | Gossamer Bio Inc. | GOSS | Maintain | Buy (N/A) |
|
Details | ||
| 12/6/2022 | Silence Therapeutics | SLN | Maintain | Buy (N/A) |
|
Details | ||
| 12/6/2022 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
| 11/21/2022 | Immunocore Holdings | IMCR | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2022 | Milestone Pharmaceuticals | MIST | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2022 | Precision BioSciences Inc. | DTIL | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2022 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2022 | Gossamer Bio Inc. | GOSS | Maintain | Buy (N/A) |
|
Details | ||
| 10/3/2022 | Irwin Naturals | IWINF | New Coverage | Buy (N/A) |
1.51 (0.22) |
-85.43% | Details | |
| 9/23/2022 | Benitec BioPharma | BNTC | Maintain | Buy (N/A) |
|
Details | ||
| 9/21/2022 | MindMed | MNMD | Maintain | Buy (N/A) |
|
Details | ||
| 4/27/2022 | Longboard Pharmaceuticals Inc | LBPH | New Coverage | Buy (N/A) |
4.80 (19.25) |
301.04% | Details | |
| 2/17/2022 | Benitec BioPharma | BNTC | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2022 | Arena Pharma | ARNA | Downgrade | Neutral (Buy) |
92.62 (99.98) |
7.95% | Details | |
| 2/8/2022 | Immunocore Holdings | IMCR | New Coverage | Buy (N/A) |
25.09 (58.00) |
131.17% | Details | |
| 2/1/2022 | Awakn Life Sciences Corp. | AWKNF | New Coverage | Buy (N/A) |
1.58 (0.14) |
-91.14% | Details | |
| 12/28/2021 | Allakos Inc. | ALLK | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2021 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 11/30/2021 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 11/23/2021 | Silence Therapeutics | SLN | Maintain | Buy (N/A) |
|
Details | ||
| 11/22/2021 | Field Trip Health Ltd. | FTRP | Maintain | Buy (N/A) |
|
Details | ||
| 10/18/2021 | atai Life Sciences N.V | ATAI | New Coverage | Buy (N/A) |
13.50 (1.84) |
-86.37% | Details | |
| 9/30/2021 | Arena Pharma | ARNA | Maintain | Buy (N/A) |
|
Details | ||
| 9/30/2021 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 9/1/2021 | Field Trip Health Ltd. | FTRP | New Coverage | Buy (N/A) |
4.81 (0.84) |
-82.54% | Details | |
| 8/18/2021 | Freeline | FRLN | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2021 | MindMed | MNMD | New Coverage | Buy (N/A) |
43.80 (8.52) |
-80.55% | Details | |
| 6/2/2021 | Altimmune | ALT | New Coverage | Buy (N/A) |
12.46 (7.20) |
-42.22% | Details | |
| 5/19/2021 | Freeline | FRLN | New Coverage | Buy (N/A) |
8.42 (6.48) |
-23.04% | Details | |
| 5/18/2021 | Allakos Inc. | ALLK | New Coverage | Buy (N/A) |
100.54 (1.01) |
-99% | Details | |
| 3/9/2021 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2021 | Milestone Pharmaceuticals | MIST | New Coverage | Buy (N/A) |
6.52 (1.58) |
-75.77% | Details | |
| 1/20/2021 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 12/22/2020 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2020 | Precision BioSciences Inc. | DTIL | New Coverage | Buy (N/A) |
8.03 (9.72) |
21.05% | Details | |
| 11/24/2020 | uniQure BV | QURE | New Coverage | Buy (N/A) |
46.50 (4.54) |
-90.24% | Details | |
| 10/14/2020 | Compass Pathways | CMPS | New Coverage | Buy (N/A) |
38.82 (7.86) |
-79.75% | Details | |
| 6/29/2020 | Arena Pharma | ARNA | New Coverage | Buy (N/A) |
65.92 (99.98) |
51.67% | Details | |
| 6/29/2020 | Gossamer Bio Inc. | GOSS | New Coverage | Buy (N/A) |
12.49 (0.67) |
-94.64% | Details |
